{"podcast":{"title":"Business Of Biotech","slug":"business-of-biotech-123501","podcast_index_feed_id":123501,"rss_url":"https://rss.buzzsprout.com/1011661.rss","website_url":"https://www.bioprocessonline.com/solution/the-business-of-biotech-podcast","image_url":"https://storage.buzzsprout.com/35u0bccu9j9xpr9zrrjias54otax?.jpg","author":"Ben Comer","episode_count":324,"summary":"The Business of Biotech is the pod dedicated to leaders of emerging biopharma firms. SUBSCRIBE to our new newsletter at www.bioprocessonline.com/bob. We bring you insight into organizational, finance and funding, HR, clinical, manufacturing, regulatory, and commercial challenges you’ll face as you navigate your company from an idea to success in the clinic and beyond. Each episode features guest commentary and best practices from accomplished founders and biopharma industry luminaries. The Business of Biotech is produced by Life Science Connect.","last_synced_at":"2026-09-14T18:21:24.973502+00:00","page_url":"https://stenobird.com/podcast/business-of-biotech-123501"},"episode":{"title":"BoB@BIO: Biotech Investing And Deals With Sofinnova's Maha Radhakrishnan, M.D.","slug":"bob-bio-biotech-investing-and-deals-with-sofinnova-s-maha-radhakrishnan-m-d","published_at":"2026-07-06T10:00:00+00:00","page_url":"https://stenobird.com/podcast/business-of-biotech-123501/bob-bio-biotech-investing-and-deals-with-sofinnova-s-maha-radhakrishnan-m-d","show_page_url":"https://stenobird.com/podcast/business-of-biotech-123501","url":"https://www.buzzsprout.com/1011661/episodes/19430442-bob-bio-biotech-investing-and-deals-with-sofinnova-s-maha-radhakrishnan-m-d.mp3","audio_url":"https://www.buzzsprout.com/1011661/episodes/19430442-bob-bio-biotech-investing-and-deals-with-sofinnova-s-maha-radhakrishnan-m-d.mp3","summary":"We love to hear from our listeners. Send us a message. This week's episode of the Business of Biotech was recorded at the BIO Convention in San Diego, where guest Maha Radhakrishnan, M.D., Executive Partner, Private Equity, at Sofinnova, spoke about her move from big pharma and biotech to private equity investing, and what makes a late-stage asset deal work. Maha also talks about how China-originated programs are changing development timelines, and where the next wave of CNS and metabolic in...","meta_description":"We love to hear from our listeners. Send us a message. This week's episode of the Business of Biotech was recorded at the BIO Convention in San Diego, whe…","key_points":[],"chapters":[],"topics":[],"duration_seconds":2347,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/business-of-biotech-123501/episodes/bob-bio-biotech-investing-and-deals-with-sofinnova-s-maha-radhakrishnan-m-d/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/business-of-biotech-123501/bob-bio-biotech-investing-and-deals-with-sofinnova-s-maha-radhakrishnan-m-d.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}